SCHEMBL5883356

SCHEMBL5883356

CCOC(C=Cc1ncc(F)cn1)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5883986 1.00 — —
SCHEMBL5883350 1.00 — —
SCHEMBL20189663 0.70 PDE2A (0.33) —
SCHEMBL20189661 0.70 PDE2A (0.33) —
SCHEMBL14529436 0.68 RAB9A (0.39) —
SCHEMBL31206006 0.68 BCHE (0.33) —
SCHEMBL18246209 0.66 — —
SCHEMBL5935639 0.66 APLNR (0.32) —
SCHEMBL18245723 0.66 — —
SCHEMBL20188451 0.66 KDM5B (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060287338-A1 Metalloproteinase inhibitor compounds ASTRAZENECA AB (SE) 2006-12-21 — — US disclosed
US-7122551-B2 Metalloproteinase inhibitor compounds ASTRAZENECA AB (SE) 2006-10-17 — — US disclosed
US-20040176386-A1 Compounds ASTRAZENECA AB (SE) 2004-09-09 — — US disclosed
US-6734183-B2 USEFUL AS METALLOPROTEINASE INHIBITOR; PIPERAZINO-SULFONAMIDE OR PIPERIDINO-SULFONAMIDE COMPOUND ASTRAZENECA AB (SE) 2004-05-11 — — US disclosed
US-20020022628-A1 Compounds ASTRAZENECA AB (SE) 2002-02-21 — — US disclosed
Send feedback